2cureX Gestione
Gestione criteri di controllo 2/4
2cureX's CEO is Ole Thastrup, appointed in Jan 2006, has a tenure of 18.83 years. total yearly compensation is SEK300.00K, comprised of 50% salary and 50% bonuses, including company stock and options. directly owns 23.8% of the company’s shares, worth SEK1.87M. The average tenure of the management team and the board of directors is 3.8 years and 2 years respectively.
Informazioni chiave
Ole Thastrup
Amministratore delegato
SEK 300.0k
Compenso totale
Percentuale dello stipendio del CEO | 50.0% |
Mandato del CEO | 18.8yrs |
Proprietà del CEO | 23.8% |
Durata media del management | 3.8yrs |
Durata media del Consiglio di amministrazione | 2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate
Jun 032cureX (STO:2CUREX) Is In A Good Position To Deliver On Growth Plans
Jan 06We're Not Very Worried About 2cureX's (STO:2CUREX) Cash Burn Rate
Sep 23We're Interested To See How 2cureX (STO:2CUREX) Uses Its Cash Hoard To Grow
Jun 02Shareholders Of 2cureX (STO:2CUREX) Must Be Happy With Their 280% Total Return
Feb 18How Does 2cureX's (STO:2CUREX) CEO Salary Compare to Peers?
Nov 29Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -SEK 26m |
Mar 31 2024 | n/a | n/a | -SEK 30m |
Dec 31 2023 | SEK 300k | SEK 150k | -SEK 33m |
Sep 30 2023 | n/a | n/a | -SEK 33m |
Jun 30 2023 | n/a | n/a | -SEK 31m |
Mar 31 2023 | n/a | n/a | -SEK 29m |
Dec 31 2022 | SEK 150k | n/a | -SEK 30m |
Sep 30 2022 | n/a | n/a | -SEK 29m |
Jun 30 2022 | n/a | n/a | -SEK 26m |
Mar 31 2022 | n/a | n/a | -SEK 25m |
Dec 31 2021 | SEK 150k | n/a | -SEK 19m |
Sep 30 2021 | n/a | n/a | -SEK 15m |
Jun 30 2021 | n/a | n/a | -SEK 10m |
Mar 31 2021 | n/a | n/a | -SEK 8m |
Dec 31 2020 | SEK 2m | SEK 2m | -SEK 7m |
Sep 30 2020 | n/a | n/a | -SEK 7m |
Jun 30 2020 | n/a | n/a | -SEK 8m |
Mar 31 2020 | n/a | n/a | -SEK 8m |
Dec 31 2019 | SEK 2m | SEK 2m | -SEK 8m |
Sep 30 2019 | n/a | n/a | -SEK 6m |
Jun 30 2019 | n/a | n/a | -SEK 6m |
Mar 31 2019 | n/a | n/a | -SEK 6m |
Dec 31 2018 | SEK 2m | SEK 2m | -SEK 7m |
Compensazione vs Mercato: Ole's total compensation ($USD28.14K) is below average for companies of similar size in the Swedish market ($USD242.77K).
Compensazione vs guadagni: Ole's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
Ole Thastrup (71 yo)
18.8yrs
Mandato
SEK 300,000
Compensazione
Mr. Ole Thastrup is CEO of 2cureX AB (publ) since June 2024 and serves as it's Vice Chairman of the Board since January 01, 2024 and served as the Chief Scientific Officer since January 2021 until January...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 18.8yrs | SEK 300.00k | 23.8% SEK 1.9m | |
Co-Founder | no data | Nessun dato | 3.87% SEK 304.0k | |
Chief Financial Officer | 3.8yrs | Nessun dato | 0.023% SEK 1.8k | |
Chief Technology Officer | less than a year | Nessun dato | 0.062% SEK 4.9k | |
Director Quality & Regulatory Affairs | no data | Nessun dato | Nessun dato |
3.8yrs
Durata media
56.5yo
Età media
Gestione esperta: 2CUREX's management team is considered experienced (3.8 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Co-Founder | 18.8yrs | SEK 300.00k | 23.8% SEK 1.9m | |
Co-Founder | less than a year | Nessun dato | 3.87% SEK 304.0k | |
Member of Clinical Advisory Board | 3.3yrs | Nessun dato | Nessun dato | |
Chairman of the Board | less than a year | Nessun dato | Nessun dato | |
Member of Clinical Advisory Board | 3.3yrs | Nessun dato | Nessun dato | |
Member of Clinical Advisory Board | 3yrs | Nessun dato | Nessun dato | |
Director | less than a year | Nessun dato | Nessun dato | |
Director | less than a year | Nessun dato | Nessun dato |
2.0yrs
Durata media
Consiglio di amministrazione esperto: 2CUREX's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.